2 Min(s) Read
The Centre has appointed Rajeev Raghuvanshi as the new Drug Controller General of India. Raghuvanshi's expertise lies in pharmaceutical innovation, and he has been involved in the development of different types of drugs. Some of these drugs include oral solids and liquids, topicals, injections, nasal sprays and more.
The Centre has appointed Rajeev Raghuvanshi as the new Drug Controller General of India (DCGI) at the Central Drugs Standard Control Organisation (CDSCO). The Appointments Committee of the Cabinet approved the recommendation submitted by the Union Public Service Commission to appoint Raghuvanshi to the post. He will be taking on the role from Dr PBN Prasad, who has been presiding over the role in a temporary manner until February 28, 2023.
Raghuvanshi is a highly accomplished pharmaceutical professional with expertise in dosage form design and development. He had been serving as the secretary-cum-science director at the Indian Pharmacopoeia Commission (IPC). He completed his Bachelor's and Master's degrees from IIT-BHU, Varanasi and his PhD from the National Institute of Immunology, New Delhi.
ALSO READ |